Clinical Trial: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Study Status: Available
Recruit Status: Available
Study Type: Expanded Access
Official Title: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Brief Summary: Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).
Detailed Summary:
Sponsor: University of California, San Francisco
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of California, San Francisco
Dates:
Date Received: July 27, 2007
Date Started:
Date Completion:
Last Updated: December 12, 2014
Last Verified: December 2014